methyl 2-amino-1,2,3,4-tetrahydro-6-bromo-2-naphthalenecarboxylate | 690254-43-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: methyl 2-amino-1,2,3,4-tetrahydro-6-bromo-2-naphthalenecarboxylate
• 英文别名: 2-amino-6-bromo-tetralin-2-carboxylic acid methyl ester；2-amino-6-bromo-1,2,3,4-tetrahydro-2-Naphthalenecarboxylic acid methyl ester；methyl 2-amino-6-bromo-3,4-dihydro-1H-naphthalene-2-carboxylate
• CAS: 690254-43-4
• 化学式: C₁₂H₁₄BrNO₂
• 分子量: 284.153
• InChiKey: QHOPTKOHLMQTAQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 2-amino-1,2,3,4-tetrahydro-6-bromo-2-naphthalenecarboxylate 在 palladium on activated charcoal lithium hydroxide 、 四(三苯基膦)钯 、 碘代三甲硅烷 、 茴香硫醚 、 (S)-(+)-扁桃酸 、 氢气 、 苯甲醚 、 三乙胺 、 N,N-二异丙基乙胺 、 fluoro-N,N,N',N'-tetramethylformamidinium hexafluorophosphate 、 三氟乙酸 作用下， 以 四氢呋喃 、 甲醇 、 乙醚 、 乙酸乙酯 、 N,N-二甲基甲酰胺 、 甲苯 、 乙腈 为溶剂， 反应 72.0h， 生成 N-((S)-2-{1-[(S)-2-Carbamoyl-1-(3-naphthalen-1-yl-propylcarbamoyl)-ethylcarbamoyl]-cyclohexylcarbamoyl}-6-phosphono-1,2,3,4-tetrahydro-naphthalen-2-yl)-oxalamic acid
  参考文献：
  名称：

  Synthesis of α,α-disubstituted 4-phosphonophenylalanine analogues as conformationally-constrained phosphotyrosyl mimetics

  摘要：

  Syntheses of N-Boc (S)-4-(diethylphosphono)-(alpha-methyl)phenylalanine [Boc-(alpha-Me)Phe(4-PO3Et2)-OH] (9) and N-Boc (S)-2amino-6-(diethylphosphono)tetralin-2-carboxylic acid [Boc-Atc(6-PO3Et2)-OH] (18) are reported as conformationally-constrained phosphotyrosyl mimetics suitably protected for peptide synthesis. Both syntheses proceeded through chiral arylhalides that are converted to arylphosphonates by palladium-catalyzed cross coupling with diethylphosphite. These amino acid analogues may be useful in the study of cellular signal transduction processes. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2004.02.005
• 作为产物：
  描述：

  6-溴-2-四氢萘酮 在 barium dihydroxide 、 氯化亚砜 、 碳酸氢铵 作用下， 以 乙醇 、 水 为溶剂， 反应 40.0h， 生成 methyl 2-amino-1,2,3,4-tetrahydro-6-bromo-2-naphthalenecarboxylate
  参考文献：
  名称：

  Synthesis of α,α-disubstituted 4-phosphonophenylalanine analogues as conformationally-constrained phosphotyrosyl mimetics

  摘要：

  Syntheses of N-Boc (S)-4-(diethylphosphono)-(alpha-methyl)phenylalanine [Boc-(alpha-Me)Phe(4-PO3Et2)-OH] (9) and N-Boc (S)-2amino-6-(diethylphosphono)tetralin-2-carboxylic acid [Boc-Atc(6-PO3Et2)-OH] (18) are reported as conformationally-constrained phosphotyrosyl mimetics suitably protected for peptide synthesis. Both syntheses proceeded through chiral arylhalides that are converted to arylphosphonates by palladium-catalyzed cross coupling with diethylphosphite. These amino acid analogues may be useful in the study of cellular signal transduction processes. (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2004.02.005

文献信息

• HETEROCYCLIC GROUP CONTAINED AMINO-METHANOL DERIVATIVE, AND SALT, SYNTHETIC METHOD AND USE THEREOF
  申请人：BEIJING FORELAND BIOPHARMA CO., LTD.

  公开号：US20150094337A1

  公开（公告）日：2015-04-02

  The present invention provides a heterocyclic group contained amino-methanol derivative, and salt, a preparation method and use thereof, and belongs to the medical field. The heterocyclic group contained amino-methanol derivative and the salt thereof of the present invention are used for preparing medicines for immune suppression and for the treatment of organ transplant rejection, or medicines for treating immune mediated inflammatory diseases, such as multiple sclerosis, systemic lupus erythematosus and rheumatoid arthritis.

  本发明提供了一种含有杂环基团的氨甲醇衍生物及其盐、制备方法和用途，属于医药领域。本发明的含有杂环基团的氨甲醇衍生物及其盐用于制备用于免疫抑制和器官移植排斥治疗的药物，或用于治疗免疫介导的炎症性疾病的药物，如多发性硬化症、系统性红斑狼疮和类风湿关节炎。
• SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS
  申请人：CAULFIELD Thomas J.

  公开号：US20100113462A1

  公开（公告）日：2010-05-06

  The present invention relates to novel compounds of the formula I: wherein in any of its stereoisomeric forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.

  本发明涉及公式I的新化合物：其中在其任何立体异构形式或立体异构形式的混合物中以任何比例，或其生理上可接受的盐，其中取代基如此描述。这些创新化合物具有CXCR5抑制活性，特别适用于治疗或预防各种炎症性疾病，例如类风湿性关节炎，多发性硬化症，红斑狼疮，克罗恩病，与人类CXCR5受体调节相关。
• US8569535B2
  申请人：——

  公开号：US8569535B2

  公开（公告）日：2013-10-29
• US9315492B2
  申请人：——

  公开号：US9315492B2

  公开（公告）日：2016-04-19
• [EN] SUBSTITUTED BENZOYLAMINO-INDAN-2-CARBOXYLIC ACIDS AND RELATED COMPOUNDS<br/>[FR] ACIDES BENZOYLAMINO-INDAN-2-CARBOXYLIQUES SUBSTITUÉS ET COMPOSÉS APPARENTÉS
  申请人：SANOFI AVENTIS

  公开号：WO2008151211A1

  公开（公告）日：2008-12-11

  [EN] The present invention relates to A compound of the formula Ia wherein in any of its stereoisomers forms or a mixture of stereoisomeric forms in any ratio, or a physiologically acceptable salt thereof, wherein the substituents are as described herein. The inventive compounds have CXCR5 inhibitory activity are particularly useful in treating or preventing various inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, lupus, Crohn's Disease, associated with the modulation of the human CXCR5 receptor.
  [FR] La présente invention concerne un composé A de formule Ia sous l'une quelconque de ses formes stéréoisomères ou un mélange de formes stéréoisomères sous un rapport quelconque, ou un sel physiologiquement acceptable de celui-ci, les substituants étant tels que décrits ici. Les composés inventifs ont une activité inhibitrice de CXCR5 et sont particulièrement utiles pour traiter ou prévenir diverses maladies inflammatoires, telles que la polyarthrite rhumatoïde, la sclérose en plaques, le lupus, la maladie de Crohn, associées à la modulation du récepteur de CXCR5 humain.